Susquehanna International Group, LLP Adma Biologics, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 308,191 shares of ADMA stock, worth $5.55 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
308,191
Previous 162,254
89.94%
Holding current value
$5.55 Million
Previous $2.78 Million
119.77%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding ADMA
# of Institutions
378Shares Held
188MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$336 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$303 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$232 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$206 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$102 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.53B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...